Key indicators: single-crystal X-ray study; T = 296 K; mean (C-C) = 0.022 Å; R factor = 0.039; wR factor = 0.105; data-to-parameter ratio = 7.0.
In the title compound, C 19 H 19 NO 13 , one of the two fused furanose rings adopts an envelope conformation whereas the other displays a twisted conformation. The crystal structure is stabilized by intermolecular C-HÁ Á Á interactions between a methine H atom and the triacetoxyphenyl ring of an adjacent molecule, and by weak non-classical intermolecular C-HÁ Á ÁO hydrogen bonds.
Related literature
For the preparation of the title compound, see: Velazquez et al. (2007) , Calmè s et al.(2003) . For related structures, see: Ezhilmuthu et al. (2008) . For the bioactivity of the title compound, see: Rigas & Williams (2008) ; Carini et al. (2002) . For puckering parameters, see: Cremer & Pople (1975) ; Rao et al. (1981) . For the determination of the absolute structure, see: van Koningsveld et al. (1984) ; Brown et al. (2000) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). (Carini et al.,2002) . 3,4,5-trihydroxybenzoic acid is a bioactivesubstance which can scavenge oxygen free radicals and Isosorbide Mononitrate is a classical nitric oxide-donor drug. This bifunctional molecule may have better bioactivity but do bring fewer side effect.
The molecule is built up from the isosorbide mononitrate skeleton substituted on C4 by the 3,4,5-triacetoxybenzoate ( Owing to the know absolute configuration of the starting isosorbide mononitrate, the absolute configuration of the title compound could be deduced to be 1S,4S,5S,8R.
The molecular packing is stabilized by weak non-classical intermolecular C-H···O hydrogen bonds and by intermolecular C-H···π interaction between methine H atom of perhydrofurofuranyl system and the triacetoxyphenyl ring of an adjacent molecule (Table 1 , Cg1 is the centroid of C42-C47 phenyl ring). (c=1.0, EtOH) and DMAP (0.24 g, 1 mmol) were dissolved in 100 ml dry THF, then DCC (4.12 g, 10 mmol) was added to the solution at 0°C. The mixture was stirred at room temperature for 5 h. The resulting mixture was filtered and concentrated in vacuo. The crude product was purified by column chromatography over silica gelusing ethyl acetate/n-hexane (7:3) as eluent. Yield: 4.21 g (85%). Single crystals of the title compound suitable for X-ray diffraction was recrystallized from hexane/ethyl acetate (1:1).
Refinement
All H atoms were positioned geometrically and treated as riding with aromatic C-H = 0.93 Å, methine C-H = 0.98 Å, methylene C-H = 0.97Å & methyl C-H = 0.96 Å. The H atom isotropic displacement parameters were fixed; U iso (aromatic H, methine H) = 1.2 times U eq of the parent atom; U iso (methylene H, methyl H) = 1.5 times U eq of the parent atom.
supplementary materials sup-2
In the absence of significant anomalous scattering, the absolute configuration could not be reliably determined and then the Friedel pairs were merged and any references to the Flack parameter were removed. The enantiomer has been assigned by reference to unchanging chiral centres in the synthetic procedure. Figures   Fig. 1 . Molecular structure of the title compound (I), showing the atom labeling scheme. Displacement ellipsoids are drawn at the 30% probability level. H atoms are represented as small spheres of arbitrary radii. Primary atom site location: structure-invariant direct methods Extinction correction: none
Special details
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes. supplementary materials sup-8 Fig. 1 
